Chemotherapy News and Research

Latest Chemotherapy News and Research

Acacia Pharma initiates two pivotal Phase 3 studies of APD421 in prevention of PONV

Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces the initiation of two pivotal Phase 3 studies of APD421 in the prevention of post-operative nausea & vomiting (PONV).

17 Sep 2013

TSRI scientists find new way to boost effectiveness of anticancer drugs

Scientists at The Scripps Research Institute (TSRI) have found a way to make dramatic improvements to the cancer cell-killing power of vinblastine, one of the most successful chemotherapy drugs of the past few decades.

17 Sep 2013

Researchers develop new variety of corked microbottle for drugs

Sustained-release formulations that release drugs over longer periods of time are not the final step in the evolution of “intelligent” drug delivery systems. Modern pharmaceuticals are being designed to be released only in a specific, diseased organ; on cues from our circadian rhythm; or under specific physiological conditions.

17 Sep 2013

Researchers find mucus-regulating protein receptors out of control in uterine, pancreatic cancers

A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, according to researchers at Rice University. The researchers offer hope for a therapeutic solution.

17 Sep 2013

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

17 Sep 2013

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute radiation syndrome (ARS).

16 Sep 2013

FDA Panel Urges Fast Approval Of Perjeta For Early-Stage Breast Cancer

...

13 Sep 2013

Funding for antimicrobial resistance research projects in the UK unacceptably small, say researchers

Study of funding awarded to antimicrobial resistance research projects in the UK calls for political leadership and sustained and targeted spending.

13 Sep 2013

Tips for parents of children with cancer

September is Childhood Cancer Awareness Month, and Lisa Diller, MD, chief medical officer of Dana-Farber/Boston Children's Cancer and Blood Disorders Center, advises parents to remain positive if their child is among the 12,000 children in the United States diagnosed with cancer each year.

13 Sep 2013

Loyola colorectal surgeon receives 2013 Robert M. Beart, MD, Impact Paper of the Year Award

Dana Hayden, MD, colorectal surgeon at Loyola University Health System accepted the 2013 Robert M. Beart, MD, Impact Paper of the Year Award from the American Society of Colon & Rectal Surgeons.

13 Sep 2013

Pertussis incidence among older adults may be under-recognized, study finds

The incidence of pertussis among U.S. adults 50 and older may be greatly under-reported and under-recognized, according to findings from a study conducted by GlaxoSmithKline researchers who analyzed approximately 48 million cases of cough-related illness in the U.S. between 2006 and 2010.

13 Sep 2013

Nanodiamonds deliver chemotherapy directly into brain tumors

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed an innovative drug-delivery system in which tiny particles called nanodiamonds are used to carry chemotherapy drugs directly into brain tumors.

13 Sep 2013

Researchers potentially reached milestone in vaccine treatment for genital herpes

Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., on today, Sept. 12.

13 Sep 2013

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.

12 Sep 2013

Dartmouth researchers find that protein cyclin A plays important role in cell division process

In a study to be published in the journal Nature, two Dartmouth researchers have found that the protein cyclin A plays an important but previously unknown role in the cell division process, acting as a master controller to ensure the faithful segregation of chromosomes during cell division.

12 Sep 2013

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

Clostridium difficile infection (CDI) treatment in a hospital setting using low dose oral vancomycin showed similar effectiveness compared to high dose, according to a new study by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University.

12 Sep 2013

CPT-F antibiotic drug may hold promise for treating potentially fatal MRSA pneumonia

A drug approved just two years ago for treating bacterial infections may hold promise for treating the potentially fatal MRSA pneumonia, according to a Henry Ford Hospital study.

12 Sep 2013

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.

12 Sep 2013

Berg receives Drug Discovery Technology Innovation Award for agnostic approach to drug discovery

Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach, was recognized today with the 2013 North American Drug Discovery Technology Innovation Award at the Frost & Sullivan Growth, Innovation and Leadership Awards Gala, the annual event by the global research organization that highlights the most promising new innovative technology across sectors.

12 Sep 2013

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

...

11 Sep 2013

Chemotherapy News and Research

Latest Chemotherapy News and Research

Acacia Pharma initiates two pivotal Phase 3 studies of APD421 in prevention of PONV

TSRI scientists find new way to boost effectiveness of anticancer drugs

Researchers develop new variety of corked microbottle for drugs

Researchers find mucus-regulating protein receptors out of control in uterine, pancreatic cancers

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

FDA Panel Urges Fast Approval Of Perjeta For Early-Stage Breast Cancer

Funding for antimicrobial resistance research projects in the UK unacceptably small, say researchers

Tips for parents of children with cancer

Loyola colorectal surgeon receives 2013 Robert M. Beart, MD, Impact Paper of the Year Award

Pertussis incidence among older adults may be under-recognized, study finds

Nanodiamonds deliver chemotherapy directly into brain tumors

Researchers potentially reached milestone in vaccine treatment for genital herpes

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Dartmouth researchers find that protein cyclin A plays important role in cell division process

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

CPT-F antibiotic drug may hold promise for treating potentially fatal MRSA pneumonia

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

Berg receives Drug Discovery Technology Innovation Award for agnostic approach to drug discovery

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in